What does Dr. EYKERMAN Magali do?

Dr. EYKERMAN Magali is a specialist medical practice in Mons. Private Limited, started on 19 March 2012, 1 establishment.

What is the address of Dr. EYKERMAN Magali?

The registered office of Dr. EYKERMAN Magali is located at Rue des Fusillés 2, 7020 Mons.

Is Dr. EYKERMAN Magali still active?

Yes. According to the CBE (2 October 2026) Dr. EYKERMAN Magali is active, legal situation “Normale toestand”, started on 19 March 2012.

Is Dr. EYKERMAN Magali registered on Peppol?

Yes, Dr. EYKERMAN Magali is registered on the Peppol network with ID 0208:0844500608.

What is the enterprise number of Dr. EYKERMAN Magali?

The enterprise number of Dr. EYKERMAN Magali is BE0844500608.

When was Dr. EYKERMAN Magali founded?

Dr. EYKERMAN Magali was founded on 19 March 2012.

Who are the directors of Dr. EYKERMAN Magali?

According to the 2025 annual accounts, the directors of Dr. EYKERMAN Magali are: Magali Eykerman.

Is Dr. EYKERMAN Magali a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 March 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. EYKERMAN Magali make in 2025?

Dr. EYKERMAN Magali recorded a loss after taxes of € 5,460 in financial year 2025.

What is the revenue of Dr. EYKERMAN Magali?

As a small company, Dr. EYKERMAN Magali is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 19,594.

Dr. EYKERMAN Magali (Private Limited) - Mons

Dossier Dr. EYKERMAN Magali, printed on 2 October 2026 from databakkes.be/en/0844500608/dr-eykerman-magali. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. EYKERMAN Magali from Mons, company number BE0844500608, closed financial year 2025 with a result of € -5,460 after tax. For that financial year Dr. EYKERMAN Magali recorded a gross margin of € 19,594 and equity of € 36,216. Compared with financial year 2024, the result moved from € 42,159 to € -5,460. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 18, 2026.

What it is worth Healthy

€ 36,216

▼ 50% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,460

▼ still € 42,159 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 100

▼ 99% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 17,616.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 36,096

▼ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 33,531

▼ 20% vs 2024

€ 8,623 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,431

▼ 34% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -13,441 Gross margin 2022: € -13,441 First fiscal year in the series	€ 10,201 Gross margin 2023: € 10,201 ▲ € 23,641 vs 2022 (€ -13,441) Favourable step	€ 64,082 Gross margin 2024: € 64,082 ▲ € 53,881 vs 2023 (€ 10,201) Favourable step	€ 19,594 Gross margin 2025: € 19,594 ▼ 69% vs 2024 (€ 64,082) Unfavourable step	▼ 69%
Profit after taxes	€ -30,643 Profit after taxes 2022: € -30,643 First fiscal year in the series	€ -6,554 Profit after taxes 2023: € -6,554 ▲ € 24,089 vs 2022 (€ -30,643) Favourable step	€ 42,159 Profit after taxes 2024: € 42,159 ▲ € 48,713 vs 2023 (€ -6,554) Favourable step	€ -5,460 Profit after taxes 2025: € -5,460 ▼ € 47,619 vs 2024 (€ 42,159) Unfavourable step	▼ € 47,619
Equity	€ 59,671 Equity 2022: € 59,671 First fiscal year in the series	€ 53,117 Equity 2023: € 53,117 ▼ 11% vs 2022 (€ 59,671) Unfavourable step	€ 72,276 Equity 2024: € 72,276 ▲ 36% vs 2023 (€ 53,117) Favourable step	€ 36,216 Equity 2025: € 36,216 ▼ 50% vs 2024 (€ 72,276) Unfavourable step	▼ 50%
Total debts	€ 27,933 Total debts 2022: € 27,933 First fiscal year in the series	€ 30,334 Total debts 2023: € 30,334 ▲ 9% vs 2022 (€ 27,933) Unfavourable step	€ 46,379 Total debts 2024: € 46,379 ▲ 53% vs 2023 (€ 30,334) Unfavourable step	€ 45,562 Total debts 2025: € 45,562 ▼ 2% vs 2024 (€ 46,379) Favourable step	▼ 2%
Cash	€ 5,085 Cash 2022: € 5,085 First fiscal year in the series	€ 19,555 Cash 2023: € 19,555 ▲ 285% vs 2022 (€ 5,085) Favourable step	€ 13,380 Cash 2024: € 13,380 ▼ 32% vs 2023 (€ 19,555) Unfavourable step	€ 100 Cash 2025: € 100 ▼ 99% vs 2024 (€ 13,380) Unfavourable step	▼ 99%
Retained profit	€ 41,071 Retained profit 2022: € 41,071 First fiscal year in the series	€ 34,517 Retained profit 2023: € 34,517 ▼ 16% vs 2022 (€ 41,071) Unfavourable step	€ 53,676 Retained profit 2024: € 53,676 ▲ 56% vs 2023 (€ 34,517) Favourable step	€ 17,616 Retained profit 2025: € 17,616 ▼ 67% vs 2024 (€ 53,676) Unfavourable step	▼ 67%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 23,000 Dividend 2024: € 23,000 Unchanged (€ 0) Unchanged	€ 30,600 Dividend 2025: € 30,600 ▲ 33% vs 2024 (€ 23,000) Unchanged	▲ 33%
Bank debt	€ 2,531 Bank debt 2022: € 2,531 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 2,531) Favourable step	€ 41,827 Bank debt 2024: € 41,827 Unchanged (€ 0) Unfavourable step	€ 33,531 Bank debt 2025: € 33,531 ▼ 20% vs 2024 (€ 41,827) Favourable step	▼ 20%
Balance sheet total	€ 87,604 Balance sheet total 2022: € 87,604 First fiscal year in the series	€ 83,451 Balance sheet total 2023: € 83,451 ▼ 5% vs 2022 (€ 87,604) Unchanged	€ 118,655 Balance sheet total 2024: € 118,655 ▲ 42% vs 2023 (€ 83,451) Unchanged	€ 81,778 Balance sheet total 2025: € 81,778 ▼ 31% vs 2024 (€ 118,655) Unchanged	▼ 31%

Key figures of Dr. EYKERMAN Magali, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. EYKERMAN Magali?

What happened at Dr. EYKERMAN Magali in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 18, 2026 New annual accounts for financial year 2025: loss of € 5,460 (▼ € 47,619 vs 2024). Source: NBB ↗
Mar 19, 2012 Start of the company according to the CBE. KBO
Mar 8, 2012 New establishment in Mons. KBO

In short

From € 30,643 loss in 2022 to € 5,460 loss in 2025.

Paid € 7,649 in corporate taxes since 2022.

Best year ever: 2024, with € 42,159 profit.

Paid out € 53,600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. EYKERMAN Magali? We notify you, reason included.

Follow Dr. EYKERMAN Magali

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Magali Eykerman

Dr. EYKERMAN Magali

Behind Dr. EYKERMAN Magali is Magali Eykerman.

See the full network in the app

Directors

According to the 2025 annual accounts

Magali Eykerman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Fusillés 2

7020 Mons

2.208.106.416

Rue des Fusillés(MJ) 2

7020 Mons

Active since 8 March 2012

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0844.500.608
VAT number: BE 0844.500.608
Registered office: Rue des Fusillés 2, 7020 Mons
Names & denominations: Dr. EYKERMAN Magali
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 March 2012
Peppol: Active · Active since 12 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗